EurekAlert! Cancer Research - News Releases

News Releases

Updates every hour. Last Updated: 5-May-2025 13:09 ET (5-May-2025 17:09 GMT/UTC)

Do firefighters face a higher brain cancer risk associated with gene mutations caused by chemical exposure?

Wiley
Peer-Reviewed Publication

Gene mutations caused by exposure to certain chemical compounds have been linked to the development of gliomas, the most common type of malignant brain tumor. New research published by Wiley online in CANCER reveals that among patients with gliomas, these mutations are more common in firefighters than in individuals with other occupations.

Journal: Cancer

New immune mechanism revealed in the cellular trash

Weizmann Institute of Science
Peer-Reviewed Publication

Research on how proteasomes generate antimicrobial peptides, revealing a new immune mechanism with potential applications for combating antibiotic resistance

Journal: Nature

Walking, moving more may lower risk of cardiovascular death for women with cancer history

American Heart Association
Reports and Proceedings

Increased physical activity including taking more daily steps was linked to a lower risk of death from cardiovascular disease among postmenopausal women with a history of cancer.

Meeting: AHA Scientific Sessions 2024

VUMC to develop AI technology for therapeutic antibody discovery

Vanderbilt University Medical Center
Grant and Award Announcement

VUMC has been awarded up to $30 million from the Advanced Research Projects Agency for Health (ARPA-H) to build a massive antibody-antigen atlas, develop AI-based algorithms to engineer antigen-specific antibodies, and apply the AI technology to identify and develop potential therapeutic antibodies.

Funder: Advanced Research Projects Agency for Health

Revolutionizing cancer treatment: targeting EZH2 for a new era of precision medicine

Compuscript Ltd
Peer-Reviewed Publication

The critical role of EZH2, an essential epigenetic regulator, in cancer progression and treatment is underscored in this new review article published in Genes & Diseases. The study highlights the transformative potential of EZH2 inhibition, paving the way for a new generation of targeted therapies aimed at disrupting tumor growth and overcoming treatment resistance.

Journal: Genes & Diseases
Funder: Research Fund for Bajian Talents of Guangdong Provincial Hospital of Chinese Medicine (China), National Natural Science Foundation of China, Foundation for Basic and Applied Research of Guangdong Province, China, Foundation for Basic and Applied Research of Guangdong Province, China, Chinese Medicine Science and Technology Research Project of Guangdong Provincial Hospital of Chinese Medicine (China), Guangzhou Science and Technology Plan Project (Guangdong, China), Guangzhou Science and Technology Plan Project (Guangdong, China), Key Project of State Key Laboratory of Dampness Syndrome of Chinese Medicine Jointly Built by Province and Ministry (China), Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases (China), Guangdong Traditional Chinese Medicine Project (China), Guangdong Traditional Chinese Medicine Project (China)

The role of ubiquitination in cancer stem cell regulation

Compuscript Ltd
Peer-Reviewed Publication

This review highlights the critical role of ubiquitination in governing the functionality of cancer stem cells (CSCs), shedding light on potential therapeutic targets for combating tumor progression, recurrence, and drug resistance. Published in Genes & Diseases, this article explores the intricate mechanisms through which the ubiquitin (Ub) system regulates key pathways essential for CSC maintenance and survival.

Journal: Genes & Diseases
Funder: National Nature Science Foundation of China, WU JIEPING Medical Foundation, Medical Science and Technology Research Project of Henan Province, China

Advancing lung cancer treatment: Understanding the differences between LUAD and LUSC

Compuscript Ltd
Peer-Reviewed Publication

Lung cancer remains one of the leading causes of cancer-related mortality, with lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) representing the most prevalent subtypes of non-small cell lung cancer (NSCLC). Despite their classification under the same umbrella, these two forms of lung cancer exhibit distinct genetic landscapes, therapeutic targets, and treatment responses.

Journal: Genes & Diseases

Unlocking the hidden proteome: The role of coding circular RNA in cancer

Compuscript Ltd
Peer-Reviewed Publication

A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor biology and a promising avenue for future therapies. Once thought to be noncoding RNA, circRNA has now been shown to encode functional proteins, challenging conventional RNA biology and opening up novel therapeutic possibilities.

Journal: Genes & Diseases
Funder: National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation of China, Shandong Provincial Natural Science Foundation of China, Shandong Provincial Natural Science Foundation of China, Shandong Provincial Natural Science Foundation of China, Special Funds for Scientific Research on Breast Diseases of Shandong Medical Association of China

Effort seeks to increase cancer-gene testing in primary care

University of Washington School of Medicine/UW Medicine
Peer-Reviewed Publication

Up to 10% of cancers are caused by genes that can be easily detected by commercially available tests. These include such common cancers as cancer of the breast, ovary, colon, stomach, uterus and pancreas. In the JAMA Network Open study published today, Dr. Elizabeth Swisher and colleagues assessed two ways that primary-care practices could assess patients’ hereditary cancer risks and deliver testing to those identified as higher risk.

Journal: JAMA Network Open
Funder: National Institute of Health Sciences

Professor Robert T. Schooley to deliver keynote at the 8th World Congress on Targeting Phage Therapy 2025

Mitochondria-Microbiota Task Force
Meeting Announcement

It is a great pleasure to announce that Professor Robert T. Schooley, from the University of California, San Diego (USA), will be a keynote speaker at the 8th World Congress on Targeting Phage Therapy, scheduled for June 10-11, 2025, in Berlin.

67
68
69
70
71